Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Knowing what to include in a beginner investment portfolio is vital for success. Learn the key elements to make informed investment choices.
22,477 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A Bloomberg-sparked rumor could change how AI compute is bought and sold. If Amazon starts selling its custom AI chip...
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
Germany plans sweeping changes to its pension system in 2026. This article breaks down what the reforms could mean fo...
As investors eye fastenal (FAST) 2026 earnings, the focus is on demand cycles, margin resilience, and cash flow stren...
A newly unsealed set of court filings details a 'honey-trap' scheme targeting a tech-family circle, underscoring how ...
Urban air mobility is moving from concept to capital-intensive reality. This article breaks down the battle royale: j...
As AI workloads rise, memory stocks grab attention. This guide lays out three scenarios for where will micron stock b...
Retirement success isn’t just about investments. The real challenge is a quiet cost you may overlook: healthcare and ...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
June is a perfect time to reset for long-term investing. Here are three practical steps that align your portfolio wit...
The wheaton precious metals stock faced a sharp June pullback as gold and silver paused. This article breaks down the...